Challenging the 10-year rule: The accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management

Journal of the Canadian Urological Association

Volumn 6, Issue 5, 2012, Pages 367-373

  Leung, Kevin M Y B ^a   Hopman, Wilma M ^a   Kawakami, Jun ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867905551     PISSN: 19116470     EISSN: None     Source Type: Journal    
DOI: 10.5489/cuaj.11161     Document Type: Review

References (28)

1. Statistics Canada. Canadian Vital Statistics, Births and Deaths Databases, Demography Division, CANSIM Table 102-0511. http://www5.statcan.gc.ca/cansim (Accessed September 11, 2012).
2. Heron M, Hoyert DL, Murphy SL, et al. Deaths: final data for 2006. Natl Vital Stat Rep 2009;57:1-134.
3. Ellison LF, De P, Mery LS, et al. Canadian cancer statistics at a glance: cancer in children. CMAJ 2009;180:422-4. http://dx.doi.org/10.1503/cmaj.081155
4. American Urological Association: Prostate-Specific Antigen Best Practice Statement: 2009. http://www. auanet.org/content/media/psa09.pdf (Accessed September 11, 2012).
5. Greene KL, Albertsen PC, Babaian RJ, et al. Prostate specific antigen best practice statement: 2009 update. J Urol 2009;182:2232-41. http://dx.doi.org/10.1016/j.juro.2009.07.093
6. Wolf AM, Wender RC, Etzioni RB, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010;60:70-98. http://dx.doi.org/10.3322/caac.20066
7. Mistry S, Mayer W, Khavari R et al: Who's Too Old To Screen? Prostate Cancer in Elderly Men. Can Urol Assoc J 2009;3:205-10.
8. Altman DG: Practical statistics for medical research. London: Chapman and Hall; 1991.
9. Pearce A, Newcomb C, Husain S. Recommendations by Canadian urologists and radiation oncologists for the treatment of clinically localized prostate cancer. Can Urol Assoc J 2008;2:197-203.
10. U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:185-91.
11. U.S. Preventive Services Task Force. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement draft 2011; 2012.
12. Andriole GL, Crawford ED, Grubb RL 3rd, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360:1310-9. http://dx.doi.org/10.1056/NEJMoa0810696
13. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-8. http://dx.doi.org/10.1056/NEJMoa0810084
14. Kirwan JR, Chaput de Saintonge DM, Joyce CR, et al. Clinical judgment in rheumatoid arthritis. I. Rheumatologists' opinions and the development of 'paper patients'. Ann Rheum Dis 1983;42:644-7. http://dx.doi.org/10.1136/ard.42.6.644
15. Christakis NA, Lamont EB. Extent and determinants of error in physicians' prognoses in terminally ill patients: prospective cohort study. West J Med 2000;172:310-3. http://dx.doi.org/10.1136/ ewjm.172.5.310
16. Wilson JR, Clarke MG, Ewings P, et al. The assessment of patient life-expectancy: how accurate are urologists and oncologists? BJU Int 2005;95:794-8. http://dx.doi.org/10.1111/j.1464-410X.2005.05403.x
17. Chow E, Davis L, Panzarella T, et al. Accuracy of survival prediction by palliative radiation oncologists. Int J Radiat Oncol Biol Phys 2005;61:870-3. http://dx.doi.org/10.1016/j.ijrobp.2004.07.697
18. Walz J, Gallina A, Perrotte P, et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int 2007;100:1254-8. http://dx.doi. org/10.1111/j.1464-410X.2007.07130.x
19. Albertsen PC, Fryback DG, Storer BE, et al. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 1996;156:127-32. http://dx.doi.org/10.1016/S0022-5347(01)65964-0
20. Krahn MD, Bremner KE, Asaria J, et al. The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer. Urology 2002;60:258-63. http://dx.doi. org/10.1016/S0090-4295(02)01712-0
21. Koch MO, Miller DA, Butler R, et al. Are we selecting the right patients for treatment of localized prostate cancer? Results of an actuarial analysis. Urology 1998;51:197-202. http://dx.doi.org/10.1016/ S0090-4295(97)00622-5
22. Henderson R, Keiding N. Individual survival time prediction using statistical models. J Med Ethics 2005;31:703-6. http://dx.doi.org/10.1136/jme.2005.012427
23. Cowen ME, Halasyamani LK, Kattan MW. Predicting life expectancy in men with clinically localized prostate cancer. J Urol 2006;175:99-103. http://dx.doi.org/10.1016/S0022-5347(05)00018-2
24. The World Health Organization. Prostate Cancer Screening 2009; 2009.
25. Izawa JI, Klotz L, Siemens DR, et al. Prostate Cancer Screening: Canadian Guidelines 2011. Can Urol Assoc J 2011;5:235-40. http://dx.doi.org/10.5489/cuaj.11134
26. Canadian Cancer Society. Understanding the Pros and Cons of Prostate Cancer Testing 2009; 2009.
27. Feightner JW. The early detection and treatment of prostate cancer: the perspective of the Canadian Task Force on the Periodic Health Examination. J Urol 1994;152:1682-4.
28. National Cancer Institute. Prostate Cancer Screening 2009; 2009.